EDWARD COLLINS: Open Payments
NPI 1144373705 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 25 payments from 9 companies in 2025. Trend: 2023 $371 · 2024 $406 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 13 | $399 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Novo Nordisk Inc | 2 | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: LEQVIO, ELIQUIS, Wegovy, Ozempic, CAMZYOS, LifeVest, OPSUMIT, REPATHA.
Industry payments across NM — which companies pay providers there.
